Erythropoietin decreases renal fibrosis in mice with ureteral obstruction

Role of inhibiting TGF-β-induced epithelial-to-mesenchymal transition

Sun Hee Park, Min Jeong Choi, In Kyung Song, Soon Youn Choi, Ju Ock Nam, Chan Duck Kim, Byung Heon Lee, Rang Woon Park, Moo Park Kwon, Yong Jin Kim, In-San Kim, Tae Hwan Kwon, Yong Lim Kim

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The inhibitory effects of recombinant human erythropoietin (rhEPO) were examined against (1) the progression of renal fibrosis in mice with complete unilateral ureteral obstruction and (2) the TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in MDCK cells. Unilateral ureteral obstruction was induced in BALB/c mice and rhEPO (100 or 1000 U/kg, intraperitoneally, every other day) or vehicle was administered from day 3 to day 14. Immunoblotting and immunohistochemistry revealed increased expressions of TGF-β1, α-smooth muscle actin (α-SMA), and fibronectin and decreased expression of E-cadherin in the obstructed kidneys. In contrast, rhEPO treatment significantly attenuated the upregulation of TGF-β1 and α-SMA and the downregulation of E-cadherin. MDCK cells were treated with TGF-β1 (5 ng/ml) for 48 h to induce EMT, and the cells were then co-treated with TGF-β1 and rhEPO for another 48 h. Increased expressions of α-SMA and vimentin and decreased expressions of zona occludens-1 and E-cadherin were observed after TGF-β1 treatment, and these changes were markedly attenuated by rhEPO co-treatment. TGF-β1 increased phosphorylated Smad-2 expression in MDCK cells, which was decreased by rhEPO co-treatment. In conclusion, rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-β1-induced EMT. It is suggested that the renoprotective effects of rhEPO could be mediated, at least partly, by inhibition of TGF-β1-induced EMT.

Original languageEnglish
Pages (from-to)1497-1507
Number of pages11
JournalJournal of the American Society of Nephrology
Volume18
Issue number5
DOIs
Publication statusPublished - 2007 May 1
Externally publishedYes

Fingerprint

Ureteral Obstruction
Epithelial-Mesenchymal Transition
Erythropoietin
Fibrosis
Kidney
Madin Darby Canine Kidney Cells
Cadherins
Therapeutics
Herpes Zoster
Vimentin
Fibronectins
Immunoblotting
Smooth Muscle
Actins
Up-Regulation
Down-Regulation
Immunohistochemistry

ASJC Scopus subject areas

  • Nephrology

Cite this

Erythropoietin decreases renal fibrosis in mice with ureteral obstruction : Role of inhibiting TGF-β-induced epithelial-to-mesenchymal transition. / Park, Sun Hee; Choi, Min Jeong; Song, In Kyung; Choi, Soon Youn; Nam, Ju Ock; Kim, Chan Duck; Lee, Byung Heon; Park, Rang Woon; Kwon, Moo Park; Kim, Yong Jin; Kim, In-San; Kwon, Tae Hwan; Kim, Yong Lim.

In: Journal of the American Society of Nephrology, Vol. 18, No. 5, 01.05.2007, p. 1497-1507.

Research output: Contribution to journalArticle

Park, Sun Hee ; Choi, Min Jeong ; Song, In Kyung ; Choi, Soon Youn ; Nam, Ju Ock ; Kim, Chan Duck ; Lee, Byung Heon ; Park, Rang Woon ; Kwon, Moo Park ; Kim, Yong Jin ; Kim, In-San ; Kwon, Tae Hwan ; Kim, Yong Lim. / Erythropoietin decreases renal fibrosis in mice with ureteral obstruction : Role of inhibiting TGF-β-induced epithelial-to-mesenchymal transition. In: Journal of the American Society of Nephrology. 2007 ; Vol. 18, No. 5. pp. 1497-1507.
@article{66fc1666c76b4888b023d3fa2d1f178d,
title = "Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: Role of inhibiting TGF-β-induced epithelial-to-mesenchymal transition",
abstract = "The inhibitory effects of recombinant human erythropoietin (rhEPO) were examined against (1) the progression of renal fibrosis in mice with complete unilateral ureteral obstruction and (2) the TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in MDCK cells. Unilateral ureteral obstruction was induced in BALB/c mice and rhEPO (100 or 1000 U/kg, intraperitoneally, every other day) or vehicle was administered from day 3 to day 14. Immunoblotting and immunohistochemistry revealed increased expressions of TGF-β1, α-smooth muscle actin (α-SMA), and fibronectin and decreased expression of E-cadherin in the obstructed kidneys. In contrast, rhEPO treatment significantly attenuated the upregulation of TGF-β1 and α-SMA and the downregulation of E-cadherin. MDCK cells were treated with TGF-β1 (5 ng/ml) for 48 h to induce EMT, and the cells were then co-treated with TGF-β1 and rhEPO for another 48 h. Increased expressions of α-SMA and vimentin and decreased expressions of zona occludens-1 and E-cadherin were observed after TGF-β1 treatment, and these changes were markedly attenuated by rhEPO co-treatment. TGF-β1 increased phosphorylated Smad-2 expression in MDCK cells, which was decreased by rhEPO co-treatment. In conclusion, rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-β1-induced EMT. It is suggested that the renoprotective effects of rhEPO could be mediated, at least partly, by inhibition of TGF-β1-induced EMT.",
author = "Park, {Sun Hee} and Choi, {Min Jeong} and Song, {In Kyung} and Choi, {Soon Youn} and Nam, {Ju Ock} and Kim, {Chan Duck} and Lee, {Byung Heon} and Park, {Rang Woon} and Kwon, {Moo Park} and Kim, {Yong Jin} and In-San Kim and Kwon, {Tae Hwan} and Kim, {Yong Lim}",
year = "2007",
month = "5",
day = "1",
doi = "10.1681/ASN.2005080866",
language = "English",
volume = "18",
pages = "1497--1507",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Erythropoietin decreases renal fibrosis in mice with ureteral obstruction

T2 - Role of inhibiting TGF-β-induced epithelial-to-mesenchymal transition

AU - Park, Sun Hee

AU - Choi, Min Jeong

AU - Song, In Kyung

AU - Choi, Soon Youn

AU - Nam, Ju Ock

AU - Kim, Chan Duck

AU - Lee, Byung Heon

AU - Park, Rang Woon

AU - Kwon, Moo Park

AU - Kim, Yong Jin

AU - Kim, In-San

AU - Kwon, Tae Hwan

AU - Kim, Yong Lim

PY - 2007/5/1

Y1 - 2007/5/1

N2 - The inhibitory effects of recombinant human erythropoietin (rhEPO) were examined against (1) the progression of renal fibrosis in mice with complete unilateral ureteral obstruction and (2) the TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in MDCK cells. Unilateral ureteral obstruction was induced in BALB/c mice and rhEPO (100 or 1000 U/kg, intraperitoneally, every other day) or vehicle was administered from day 3 to day 14. Immunoblotting and immunohistochemistry revealed increased expressions of TGF-β1, α-smooth muscle actin (α-SMA), and fibronectin and decreased expression of E-cadherin in the obstructed kidneys. In contrast, rhEPO treatment significantly attenuated the upregulation of TGF-β1 and α-SMA and the downregulation of E-cadherin. MDCK cells were treated with TGF-β1 (5 ng/ml) for 48 h to induce EMT, and the cells were then co-treated with TGF-β1 and rhEPO for another 48 h. Increased expressions of α-SMA and vimentin and decreased expressions of zona occludens-1 and E-cadherin were observed after TGF-β1 treatment, and these changes were markedly attenuated by rhEPO co-treatment. TGF-β1 increased phosphorylated Smad-2 expression in MDCK cells, which was decreased by rhEPO co-treatment. In conclusion, rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-β1-induced EMT. It is suggested that the renoprotective effects of rhEPO could be mediated, at least partly, by inhibition of TGF-β1-induced EMT.

AB - The inhibitory effects of recombinant human erythropoietin (rhEPO) were examined against (1) the progression of renal fibrosis in mice with complete unilateral ureteral obstruction and (2) the TGF-β1-induced epithelial-to-mesenchymal transition (EMT) in MDCK cells. Unilateral ureteral obstruction was induced in BALB/c mice and rhEPO (100 or 1000 U/kg, intraperitoneally, every other day) or vehicle was administered from day 3 to day 14. Immunoblotting and immunohistochemistry revealed increased expressions of TGF-β1, α-smooth muscle actin (α-SMA), and fibronectin and decreased expression of E-cadherin in the obstructed kidneys. In contrast, rhEPO treatment significantly attenuated the upregulation of TGF-β1 and α-SMA and the downregulation of E-cadherin. MDCK cells were treated with TGF-β1 (5 ng/ml) for 48 h to induce EMT, and the cells were then co-treated with TGF-β1 and rhEPO for another 48 h. Increased expressions of α-SMA and vimentin and decreased expressions of zona occludens-1 and E-cadherin were observed after TGF-β1 treatment, and these changes were markedly attenuated by rhEPO co-treatment. TGF-β1 increased phosphorylated Smad-2 expression in MDCK cells, which was decreased by rhEPO co-treatment. In conclusion, rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-β1-induced EMT. It is suggested that the renoprotective effects of rhEPO could be mediated, at least partly, by inhibition of TGF-β1-induced EMT.

UR - http://www.scopus.com/inward/record.url?scp=34248191263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248191263&partnerID=8YFLogxK

U2 - 10.1681/ASN.2005080866

DO - 10.1681/ASN.2005080866

M3 - Article

VL - 18

SP - 1497

EP - 1507

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 5

ER -